Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
Authors:
- 1 March 2006
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (2) , 549-555
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 casesVirchows Archiv, 2005
- Expression of COX-2 proteins in gastric mucosal lesionsWorld Journal of Gastroenterology, 2004
- Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian CancerGynecologic Oncology, 2002
- Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian CarcinomaThe American Journal of Pathology, 2002
- Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancerBritish Journal of Cancer, 2000
- Nitric oxide and cell deathBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999
- Cyclooxygenase-2 Overexpression Enhances Lymphatic Invasion and Metastasis in Human Gastric CarcinomaAmerican Journal of Gastroenterology, 1999
- Immunohistochemical characterizationof nitric oxide synthase activity in squamous cell carcinoma of the head and neckOtolaryngology–Head and Neck Surgery, 1995
- Nitric oxide synthase activity in human breast cancerBritish Journal of Cancer, 1995
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994